LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

EKF Diagnostics Presents Latest Diabetes Care Analyzers

By LabMedica International staff writers
Posted on 31 Jan 2019
Image: The Lactate Scout 4 analyzer for athletes (Photo courtesy of EKF Diagnostics).
Image: The Lactate Scout 4 analyzer for athletes (Photo courtesy of EKF Diagnostics).
EKF Diagnostics (Cardiff, Wales, UK) presented its latest diabetes care analyzers at MedLab Middle East, a leading laboratory and flagship exhibition and conference spanning across the Middle East, Asia and West Europe. MedLab Middle East 2019 provided an international platform for laboratory management and medicine to exhibit their products ranging from ayurvedic & herbal to medical & pharmaceutical essentials in medical research & development & scientific instruments. The Conference provided education, best practices and the chance to learn, meet and network with leading laboratorians from across the globe.

At MedLab Middle East, EKF Diagnostics displayed DiaSpect Tm, the world’s fastest hemoglobin analyzer that delivers laboratory quality results in just about one second of the microcuvette being placed into the analyzer. The hemoglobin analyzer is palm-sized, making it easily transportable, and ideal for use in any screening setting even in challenging climatic environments. EKF Diagnostics also exhibited the Quo-Lab HbA1c desktop point-of-care analyzer for measuring glycated hemoglobin (HbA1c). The semi-automated analyzer has been designed specifically to meet the needs of diabetes clinics and laboratories in settings that demand low cost of operation and ease of use.

Also on display at the event was EKF Diagnostics’ Quo-Test HbA1c system, a fully automated HbA1c analyzer that uses patented boronate affinity fluorescence quenching technology to measure HbA1c from a 4-μl sample taken from a finger prick or venous whole blood. It has been designed for easy and reliable HbA1c measurement for the monitoring and management of diabetes in a point-of-care setting such as diabetes clinics and doctors’ surgeries. EKF Diagnostics’ also exhibited Hemo Control, its point-of-care hemoglobin analyzer designed to provide quantitative, lab quality hemoglobin results from 25 seconds. Hemo Control uses the most established photometric azide methemoglobin method, ensuring reliable results with a high precision (CV <2%).

Among the latest products displayed by EKF Diagnostics at MedLab Middle East was its new Lactate Scout 4 lactate analyzer for athletes. Lactate Scout 4 is used by sports medicine and sport professionals for the easy and reliable measurement of lactate while training on the track, working out in the gym or analyzing their performance in the laboratory. It has been ergonomically designed to be effectively used in the field as a training companion for coaches and athletes to determine optimum training programs, define training zones, and avoid inefficient training exercises. The hand-held lactate analyzer requires just 0.2 µl of capillary blood and returns results in 10 seconds. Up to 500 results can be stored on the Lactate Scout 4, which also features easy connection to heart rate monitors, stopwatch function to aid performance measurement, integrated step test function and Bluetooth connectivity.

Gold Member
Automatic Hematology Analyzer
DH-800 Series
Collection and Transport System
PurSafe Plus®
Capillary Blood Collection Tube
IMPROMINI M3
Gold Member
Hematology Analyzer
Medonic M32B

Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: Private equity firms Blackstone and TPG have joined forces to acquire Hologic in a major healthcare deal (Photo courtesy of Hologic)

Hologic to be Acquired by Blackstone and TPG

Hologic (Marlborough, MA, USA) has entered into a definitive agreement to be acquired by funds managed by Blackstone (New York, NY, USA) and TPG (San Francisco, CA, USA) in a transaction valued at up to... Read more